Video transcript
On Screen Text
Reconstitution and Administration
Audio
Welcome, this video will walk you through the reconstitution and administration process for AREXVY.
On Screen Text
How Supplied; Preparation
Reconstitution and Administration
Audio
Important information about how AREXVY is supplied will also be discussed.
On Screen Text
How Supplied
AREXVY 0.5 mL IM Injection
1. Adjuvant suspension component (liquid)
2. Lyophilized antigen component (powder)
Reconstitution and Administration
Audio
AREXVY is supplied in 2 vials, an adjuvant suspension component (liquid) and a lyophilized antigen component (powder), that must be combined prior to administration. Use only the supplied adjuvant suspension component for reconstitution.
On Screen Text
How Supplied
Refrigerated
Between 2-8°C (36-46°F)
Protect From Light
Do Not Freeze
Reconstitution and Administration
Audio
Prior to reconstitution, store both the adjuvant suspension component vials and the lyophilized antigen component vials refrigerated between 2 degrees Celsius and 8 degrees Celsius (36 to 46 degrees Fahrenheit). Store in the original package in order to protect vials from light. Do not freeze. Discard if the adjuvant suspension component or the antigen component have been frozen.
On Screen Text
Preparation
Reconstitution and Administration
Audio
When you are ready to reconstitute the vaccine, follow these steps.
On Screen Text
Preparation
Step A: Withdraw the entire contents of the vial containing the adjuvant suspension component (liquid).
Step B: Slowly transfer the entire contents of the syringe into the lyophilized antigen component vial (powder).
Step C: Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously.
Wash your hands or wear gloves. Preparation will also require needles, syringes, disinfecting swabs, and a bandage.
DO NOT SHAKE VIGOROUSLY
Reconstitution and Administration
Audio
Check the expiration date of both vials. If expired, do not use. Cleanse both vial stoppers with a sterile alcohol swab. Using sterile needles and sterile syringes, withdraw the entire contents of the vial containing the adjuvant suspension component (liquid) by slightly tilting the vial.
Slowly transfer the entire contents of the syringe into the lyophilized antigen component vial (powder).
Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously. The reconstituted vaccine should be an opalescent, colorless to pale brownish liquid.
On Screen Text
Preparation
Refrigerated
Between 2-8°C (36-46°F) or at Room Temperature up to 25°C (77°F)
Protect From Light
Discard Reconstituted Vaccine if Not Used Within 4 Hours
Do Not Freeze
Reconstitution and Administration
Audio
After reconstitution, administer AREXVY immediately or store protected from light in the refrigerator between 2 degrees Celsius and 8 degrees Celsius (36 to 46 degrees Fahrenheit) or at room temperature up to 25 degrees Celsius (77 degrees Fahrenheit) and use within 4 hours. Discard reconstituted vaccine if not used within 4 hours. Do not freeze. Discard if the vaccine has been frozen.
On Screen Text
Preparation
Prior to administration, inspect for particulate matter and discoloration
Questions about AREXVY?
Call 877-AREXVY1 (877-273-9891)
Reconstitution and Administration
Audio
Immediately prior to administering, parenteral drug products should be inspected visually for particulate matter and discoloration immediately prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.
On Screen Text
Preparation
STEP D: After reconstitution, withdraw 0.5 mL from the vial containing the reconstituted vaccine and administer intramuscularly.
AREXVY is for intramuscular injection only
For illustrative purposes only.
Reconstitution and Administration
Audio
After reconstitution, if stored, cleanse the vial stopper with a sterile alcohol swab prior to administration. Withdraw 0.5 mL from the vial containing the reconstituted vaccine. Disinfect the injection site prior to administration, and administer intramuscularly. AREXVY is for intramuscular injection only.
On Screen Text
GSK Logo
Trademarks are owned by or licensed to the GSK group of companies.
©2023 GSK or licensor.
RSASTBD230013 June 2023
Produced USA.
close
